Member Info for Matador78

Longlad do you shake your fist at the clouds?

Very good ODonnell. Slyly does it.

Excellent deduction of a failing character actor.

Well done Reefles.

I dont understand what youre implying O'Donnell is there any particular reason you think Adam wouldnt be holding at the minute?

You should moan more. It has a direct correlation with SP rise.

The delay was caused by

*World Events Pandemic ( Out of our control)
*Leaps accounts not being kept in good order pre Ed. (That's on Yarivs Head)
*Invasion of host City Kiev (Russias Fault)
*Lack of IPO specialists ( General Market Mechanics )

It'll happen when it happens

The market isnt in its best place to raise an IPO.

Timing is everything. No point forcing it through it=f there's little appetite.

Cheers Tak, at first read my post does sound a bit arrogant but if you read the post by fatman it makes more sense. Ive never been described as hubristic or arrogant before as its two traits that knock me sick in other people. Either way were in for a turbulent few weeks or months.

I honestly don't care what someone like you thinks of me barwick. You're irrelevant.

Cheers Fatty, Its not always in the bods interest to be as informative as me. Sometimes I have to weigh up whether or not to post certain finds. If someone keeping quiet its usually for good reason.

Presumably whoever's buying will do it in daily increments now.

We''ll creep back up into news no doubt

No one knows if a Leap IPO has been started other than Ed and Leap. He did say yesterday that they had to created a listed entity and provide accounts, From what I gather Yariv wasn't great about his bookkeeping before Ed moved in to sort it out,.

Not so much you Fatty

Ive never criticised questioning investments. I will criticize however people being purposefully negative in order to talk down an investment.

Take ciitech for instance complete incompetence by everyone involved (Bar Seed) luckily we only have a small holding and they'll go private as and when.

This Palm Oil wont be "farmed" anywhere. Not in the traditional sense anyway,

I've put screen shots and links out Barwick since 3 weeks ago regarding it. Nothing I say is set in stone because im not privvy to inside information, It is in the same vain as the information I found about EMMAC when it was a baby.

Im not professing certainty. I'm professing probability

Well it's likely a consensus was agreed on where the bottom was and hopefully this is it. That together with the portfolio ticking along and not under any particular stress.

But Ed's hint about whats coming next seems to be being ignored here. I can tell you it involves Palm Oil and various necessary food items.

I'm pretty psyched for that as it gives me something to focus on other than Cannabis.

Cont...
On the occasion of the five-year anniversary of the Cannabis as Medicine Act, the company specializing in cannabis extracts and active ingredients with roots in phytopharmaceuticals draws a first positive balance. "Five years ago, Germany boldly opened up the market for the use of cannabis as a medicinal product to address the unmet need of seriously ill patients. The Ministry of Health's companion survey on the use of medicinal cannabis in this country will show that while the potential of cannabis therapy recognizable, but it is too often not sufficiently evidence-based. We are therefore focusing on investing in research and development and manufacturing corresponding products in the coming years," says Bernhard Babel, Co-CEO of Eurox Pharma.

A spirit of innovation and research are required for targeted therapy with medical cannabis. It is also crucial to develop innovative and targeted products in close cooperation with researchers, doctors and pharmacists. "As a leading company in German and European phytopharmaceuticals, we want to contribute our expertise in the development of high-quality medicines. It starts with the close exchange of experience with prescribing doctors and pharmacists. This allows us to constantly develop and improve our product portfolio," Babel continues.

The Cannabis as Medicine Act was created to ensure the supply of medical cannabis in Germany for serious illnesses. With the completion of the Companion Survey approaching, this testing phase is now over.

It is now a question of setting clear evidence standards for the use of cannabis as a medicinal product - just as with other medicinal products. Five years of the Cannabis as Medicine Act should be the reason to continue to ensure research and development for high-quality medicinal products in the cannabis sector. Eurox Pharma wants to make a contribution to this and thinks long-term and sustainably in the interests of the patients instead of focusing on short-term profits or the leisure market, which will soon be legal.

Exactly five years after the historic cannabis as medicine law came into force in Germany, the Hessian company Eurox is entering the German market. The company has set itself the goal of making therapy with cannabis-based medicines more patient-oriented and effective by making targeted investments in the expansion of scientific evidence. Eurox specializes in the production of precisely adjusted cannabis extracts and the active ingredient dronabinol.

The cannabis-as-medicine law is a unique success story. With this law, Germany has laid the basis for the evidence-based use of cannabis for the first time.
The results of the accompanying survey by the Federal Ministry of Health will show that the use of medicinal cannabis is becoming increasingly accepted in Germany. In the context of the planned legalization of cannabis, it is therefore all the more important that the scientific basis for therapy with cannabis-based medicinal products is significantly expanded so that the safety and effectiveness for patients can be clearly proven.
Eurox Pharma prioritizes research and development. In collaboration with physicians, pharmacists and researchers, the company aims to create evidence-based products that meet the specific needs of patients, rather than just marketing another cannabis product for profit.

Well I'll post it here to prove that I'm willing to deliver the Bad with the good.

https://www.proactiveinvestors.co.uk/companies/news/976222/diurnal-dips-as-bosses-give-investor-presentation-976222.html